Contract 36C26025F0209
Actelion Pharmaceuticals Us, Inc. · Department Of Veterans Affairs · March 2, 2026
Actelion Pharmaceuticals Us, Inc. was awarded a federal contract by Department Of Veterans Affairs on March 2, 2026 for $3,000 of work in pharmaceutical preparation manufacturing. Performance is in Memphis, TN. This is a task or delivery order issued under parent IDIQ 36F79724D0159. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $197,000.
Contract details
- PIID
- 36C26025F0209
- Parent IDIQ
- 36F79724D0159
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Memphis, TN
- First action
- March 2, 2026
Description
UPTRAVI 1600MCG TAB. 2026 PRICE INCREASE
Modification timeline
-
March 2, 2026Mod P00001 · Funding Only Action$197.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26025F0209?
Contract 36C26025F0209 is a federal contract awarded to Actelion Pharmaceuticals Us, Inc. by Department Of Veterans Affairs on March 2, 2026 for $3,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 36C26025F0209?
Actelion Pharmaceuticals Us, Inc. won contract 36C26025F0209 from Department Of Veterans Affairs.
How much is contract 36C26025F0209 worth?
Contract 36C26025F0209 has obligated $3,000 to date, with a total potential value of $197,000 if all options are exercised.